Our results suggest that the addition of tumour immunohistochemical expression can add value to the classification of likely causal BRCA1 variants using multifactorial likelihood analysis and that functional assays are a useful adjunct to multifactorial analysis. Here, BRCA1 is linked to neoplasm.